Uncoupling Protein 2 (UCP2)
Overview
flowchart TD
UCP2["UCP2"] -->|"inhibits"| Als["Als"]
UCP2["UCP2"] -->|"activates"| Obesity["Obesity"]
UCP2["UCP2"] -->|"activates"| Inflammation["Inflammation"]
UCP2["UCP2"] -->|"activates"| Als["Als"]
UCP2["UCP2"] -->|"activates"| Immune_Response["Immune Response"]
UCP2["UCP2"] -->|"regulates"| Cardiac["Cardiac"]
UCP2["UCP2"] -->|"regulates"| Ms["Ms"]
UCP2["UCP2"] -->|"regulates"| Ischemia["Ischemia"]
UCP2["UCP2"] -->|"inhibits"| Melanoma["Melanoma"]
UCP2["UCP2"] -->|"inhibits"| Inflammation["Inflammation"]
UCP2["UCP2"] -->|"activates"| Fatty_Liver["Fatty Liver"]
UCP2["UCP2"] -->|"activates"| Diabetes["Diabetes"]
UCP2["UCP2"] -->|"activates"| Aging["Aging"]
UCP2["UCP2"] -->|"activates"| Neuroinflammation["Neuroinflammation"]
style UCP2 fill:#4fc3f7,stroke:#333,color:#000
...
Uncoupling Protein 2 (UCP2)
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">Uncoupling Protein 2 (UCP2)</th> </tr> <tr> <td class="label">Symbol</td> <td><strong>UCP2</strong></td> </tr> <tr> <td class="label">Full Name</td> <td>Uncoupling 2 (UCP2)</td> </tr> <tr> <td class="label">Type</td> <td>Protein</td> </tr> <tr> <td class="label">UniProt</td> <td><a href="https://www.uniprot.org/uniprot/?query=UCP2" target="_blank">Search UniProt</a></td> </tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/fatty-liver" style="color:#ef9a9a">Fatty Liver</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">76 edges</a></td> </tr> </table>
Uncoupling Protein 2 is a protein that ucp2 is a mitochondrial anion carrier protein that uncouples oxidative phosphorylation:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target. [@zhang2011]
[@khalife2023]
Structure UCP2 is a member of the mitochondrial carrier protein family. It contains:
Six transmembrane alpha-helices : Form the mitochondrial inner membrane transport channel
Three repeat motifs : Characteristic of mitochondrial carriers
Nucleotide-binding pocket : Bind nucleotides (ATP, GDP)
Matrix and intermembrane space domains : Regulatory regions
UCP2 forms homodimers in the inner mitochondrial membrane and functions as a regulated proton transporter.
Normal Function UCP2 is a mitochondrial anion carrier protein that uncouples oxidative phosphorylation:
Proton leak : Dissipates the proton gradient across the inner mitochondrial membrane
Thermogenesis : Generates heat without ATP production
Metabolic regulation : Modulates cellular energy efficiency
ROS Regulation
Mitochondrial ROS reduction : Decreases [reactive oxygen species](/entities/reactive-oxygen-species) production
Oxidative stress protection : Limits ROS-induced cellular damage
Antioxidant function : Protects against oxidative damage
Cellular Signaling
Nutrient sensing : Coordinates metabolism with nutrient availability
Insulin secretion : Modulates pancreatic beta-cell function
Immune regulation : Affects macrophage and T-cell function
Role in Neurodegeneration
Parkinson's Disease UCP2 plays a significant protective role in PD:
Mitochondrial protection : Maintains mitochondrial function in dopaminergic [neurons](/entities/neurons)
ROS reduction : Decreases oxidative stress in the substantia nigra
[Alpha-synuclein](/proteins/alpha-synuclein) aggregation : May influence aggregation dynamics
Neuroprotection : UCP2 upregulation protects against MPTP toxicity
Alzheimer's Disease UCP2 involvement in AD:
[Amyloid-beta](/proteins/amyloid-beta) toxicity : UCP2 deficiency worsens Aβ-induced neuronal death
Mitochondrial dysfunction : Early event in AD pathogenesis
Cognitive function : UCP2 expression correlates with memory performance
Therapeutic target : UCP2 activators show promise in AD models
Amyotrophic Lateral Sclerosis
Motoneuron protection : UCP2 overexpression extends survival in SOD1 models
Mitochondrial quality control : Maintains mitochondrial integrity
Energy metabolism : Supports high energy demands of motoneurons
Huntington's Disease
Mitochondrial dysfunction : UCP2 alterations contribute to metabolic deficits
Neuroprotection : UCP2 upregulation improves phenotype in HD models
Energy metabolism : Modulates the altered energy metabolism in HD
Therapeutic Targeting
UCP2 activators : Genipin, naturally-occurring UCP2 activator
Gene therapy : AAV-mediated UCP2 overexpression
Mitochondrial-targeted antioxidants : Combine ROS reduction with UCP2 activation
Key Publications
[Andrews et al., Uncoupling protein-2: a novel therapeutic target for neurodegenerative diseases (2005)](https://doi.org/10.1016/j.tips.2005.08.005)
[Conti et al., UCP2 in Parkinson's disease: The role of mitochondrial uncoupling in neurodegeneration (2019)](https://doi.org/10.1016/j.neuroscience.2019.05.024)
[Du et al., UCP2 protects against amyloid-beta neurotoxicity via mitochondria-dependent pathway (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.03.011)
[Peixoto et al., UCP2 deficiency increases ROS in models of ALS (2018)](https://doi.org/10.1016/j.nbd.2018.04.016)
[Kim-Han et al., The mitochondrial uncoupling protein UCP2: A therapeutic target in neurodegeneration (2021)](https://doi.org/10.1016/j.pharmthera.2021.107859)
See Also
[UCP2 Gene](/genes/ucp2)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Mitochondrial Dysfunction in Neurodegeneration](/mechanisms/mitochondrial-dysfunction-neurodegeneration)
[Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress-neurodegeneration)
[Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
External Links
[UniProt P55851](https://www.uniprot.org/uniprot/P55851)
[NIH Genetic Testing Registry - UCP2](https://www.ncbi.nlm.nih.gov/gtr/genes/7351/)
[Human Protein Atlas - UCP2](https://www.proteinatlas.org/ENSG00000175567-UCP2)
References
[Zhang et al., Uncoupling protein 2: A potential target for neurodegenerative diseases (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21917523/)
[Lee et al., UCP2 in amyotrophic lateral sclerosis model (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24141050/)
[Andrews et al., Ghrelin protects nigrostriatal dopamine function via UCP2 (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/19906954/)
[Donnelly et al., UCP2 in glial response to stress, neuroprotection (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27651753/)
[Ramsden et al., UCP2 as protective stress signal in neuronal injury (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12147286/)
[Mercer et al., UCP2 and mitochondrial dysfunction in neurodegenerative diseases (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26468156/)
[Pers et al., Mitochondrial uncoupling proteins in the brain: Roles in neurodegeneration (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27236505/)
[Volta et al., UCP2 deficiency exacerbates neuroinflammation in Parkinson's disease (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32864155/)
[Deng et al., UCP2-mediated metabolic regulation in dopaminergic neurons (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29898765/)
[Khalife et al., Targeting mitochondrial UCP2 for neuroprotection (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/38021699/)
Pathway Diagram The following diagram shows the key molecular relationships involving Uncoupling Protein 2 (UCP2) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description